Anterios registers $57.5 million of stock for initial public offering

Stifel and RBC Capital Markets, JMP Securities and Needham will assist

By Devika Patel

Knoxville, Tenn., March 31 – Anterios, Inc. will conduct an initial public offering of its common stock with a 30-day greenshoe, according to a Form S-1 filed Tuesday with the Securities and Exchange Commission. The company has registered up to $57.5 million of stock.

Stifel, Nicolaus & Co. Inc. and RBC Capital Markets LLC are the bookrunning managers. JMP Securities LLC and Needham & Co. LLC are the co-managers.

Proceeds will be used for clinical development, clinical trials, working capital and general corporate purposes.

Based in New York, Anterios is a biopharmaceutical company. The company intends to list its common stock on the Nasdaq under the symbol “ANTE.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.